Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carel le Roux

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
International Journal of Qualitative Studies on Health and Well-Being|April 25, 2024
"Treated as second class citizens" - the lived experience of obesity-related stigma: an IMI2 SOPHIA studyEva Hollmann, Emma Farrell, Carel Le Roux, et al.
Obesity Science & Practice|June 12, 2020
Double-blinded, randomized, and controlled study on the effects of canagliflozin after bariatric surgery: A pilot studySangeeta R Kashyap, Karim Kheniser, Ali Aminian, et al.
Obesity Facts|November 18, 2017
Comparison of Efficacy and Safety of Liraglutide 3.0 mg in Individuals with BMI above and below 35 kg/m²: A Post-hoc AnalysisCarel le Roux, Vanita Aroda, Joanna Hemmingsson, et al.
Obesity Science & Practice|January 24, 2024
Patient perspectives about treatment preferences for obesity with complicationsHilary C Craig, Dalal Alsaeed, Suzanne Norris, et al.
Public Health Research & Practice|October 11, 2022
A better understanding of the science and reality of obesity is urgently neededTiffany Petre, Adrian Bauman, Priya Sumithran, et al.
Obesity Surgery|July 18, 2020
Continuous Glucose Monitoring of Glycemic Variability During Fasting Post-Sleeve GastrectomyEbaa Al-Ozairi, Abeer El Samad, Jumana Al Kandari, et al.
Obesity Surgery|February 17, 2018
EndoBarrier®: a Safe and Effective Novel Treatment for Obesity and Type 2 Diabetes?Nisha Patel, Aruchuna Mohanaruban, Hutan Ashrafian, et al.
BMJ Open|July 25, 2022
Medication following bariatric surgery for type 2 diabetes mellitus (BY-PLUS) study: rationale and design of a randomised controlled studyAlexis Sudlow, Alexander Dimitri Miras, Ricardo Vitor Cohen, et al.
BMJ Open|May 7, 2026
Treatment of the disease of obesity in patients with type 1 diabetes with tirzepatide: a protocol for a randomised controlled trial in a single-centre settingEbaa Al Ozairi, Ameenah Al Awadhi, Etab Taghadom, et al.
BMJ Open|February 16, 2020
Effectiveness and cost of integrating a pragmatic pathway for prescribing liraglutide 3.0 mg in obesity services (STRIVE study): study protocol of an open-label, real-world, randomised, controlled trialDimitris Papamargaritis, Werd Al-Najim, Jonathan Lim, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
International Journal of Qualitative Studies on Health and Well-Being|April 25, 2024
"Treated as second class citizens" - the lived experience of obesity-related stigma: an IMI2 SOPHIA studyEva Hollmann, Emma Farrell, Carel Le Roux, et al.
Obesity Science & Practice|June 12, 2020
Double-blinded, randomized, and controlled study on the effects of canagliflozin after bariatric surgery: A pilot studySangeeta R Kashyap, Karim Kheniser, Ali Aminian, et al.
Obesity Facts|November 18, 2017
Comparison of Efficacy and Safety of Liraglutide 3.0 mg in Individuals with BMI above and below 35 kg/m²: A Post-hoc AnalysisCarel le Roux, Vanita Aroda, Joanna Hemmingsson, et al.
Obesity Science & Practice|January 24, 2024
Patient perspectives about treatment preferences for obesity with complicationsHilary C Craig, Dalal Alsaeed, Suzanne Norris, et al.
Public Health Research & Practice|October 11, 2022
A better understanding of the science and reality of obesity is urgently neededTiffany Petre, Adrian Bauman, Priya Sumithran, et al.
Obesity Surgery|July 18, 2020
Continuous Glucose Monitoring of Glycemic Variability During Fasting Post-Sleeve GastrectomyEbaa Al-Ozairi, Abeer El Samad, Jumana Al Kandari, et al.
Obesity Surgery|February 17, 2018
EndoBarrier®: a Safe and Effective Novel Treatment for Obesity and Type 2 Diabetes?Nisha Patel, Aruchuna Mohanaruban, Hutan Ashrafian, et al.
BMJ Open|July 25, 2022
Medication following bariatric surgery for type 2 diabetes mellitus (BY-PLUS) study: rationale and design of a randomised controlled studyAlexis Sudlow, Alexander Dimitri Miras, Ricardo Vitor Cohen, et al.
BMJ Open|May 7, 2026
Treatment of the disease of obesity in patients with type 1 diabetes with tirzepatide: a protocol for a randomised controlled trial in a single-centre settingEbaa Al Ozairi, Ameenah Al Awadhi, Etab Taghadom, et al.
BMJ Open|February 16, 2020
Effectiveness and cost of integrating a pragmatic pathway for prescribing liraglutide 3.0 mg in obesity services (STRIVE study): study protocol of an open-label, real-world, randomised, controlled trialDimitris Papamargaritis, Werd Al-Najim, Jonathan Lim, et al.
Pageof 4